Revenue

Advantage Solutions overhauls its board, adding heavyweights in capital markets and commercial strategy to navigate a pivotal transformation and retail industry shifts.

With 66% of Gen Z learning skills online, the resume is changing. How can employers tell real expertise from noise in a new skill-based economy?

With promising preclinical data and Australian trial approval, Kivu’s KIVU-305 aims to overcome past failures in targeting aggressive solid tumors.

Rgenta Therapeutics unveils a promising oral drug that targets the genetic root of Huntington's, offering a new beacon of hope for patients.

New subgroup data from ITM's COMPETE trial could refine treatment for a tough-to-treat cancer and bolster the company's position in the radiopharma market.

The sale of the 344-unit Esperanza at Duarte Station highlights strong demand for transit-oriented luxury living, even as the broader LA market cools.

With legendary geologist Doug Kirwin and Latin America expert Carlos Velásquez on board, Terra Rossa is set to unlock its high-grade Vetas gold project.

At MWC 2026, First Orion unveils its expanded Global Exchange, adopting CAMARA APIs to fight spam and double its branded calling reach by year-end.

The spirits giant faces a steep sales decline and a massive write-down, pivoting to premium brands and operational fixes amid an industry-wide hangover.

In a landmark move, mitú appoints Vanessa Vigil as President. Her rise signals a new chapter for the media giant and a milestone for Latina leadership.

AI-first firms face a hidden 'tax,' taking 80 days longer and paying 135% more to recover from cyberattacks, a new report from Fastly reveals.

Strategic Resources navigates a key environmental review for its iron ore pellet plant, tapping into Quebec's hydro power for the global green steel market.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

After a breakout first year, Maine's sustainable canned water brand is expanding into Boston and Florida, leveraging its pure origins and a veteran sales team.

Intellicheck's new desktop tool promises immediate, advanced identity verification without complex integration, leveling the security field for businesses.

Investors sue Corcept Therapeutics, claiming the company hid FDA warnings about its key drug, relacorilant, before a 50% stock price collapse.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

The denim giant is doubling down on Gen Z by sponsoring the world's largest country music festival and enlisting stars Bailey Zimmerman and Ella Langley.

New research shows assessment fraud more than doubled in 2025, driven by AI and hitting entry-level roles hardest. How can companies ensure fair hiring?

As AI adoption stalls at the pilot stage, new labs in Singapore, Japan, and the UK offer a crucial sandbox for testing high-stakes hybrid cloud deployments.